Andrew Cooper
Stock Analyst at Raymond James
(0.74)
# 4,135
Out of 4,703 analysts
207
Total ratings
40.9%
Success rate
-1.9%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Maintained: Buy | $105 → $125 | $102.92 | +21.45% | 15 | Sep 3, 2026 | |
| ITGR Integer Holdings | Downgraded: Hold | n/a | $126.50 | - | 7 | Aug 3, 2026 | |
| HCA HCA Healthcare | Reiterated: Hold | n/a | $405.00 | - | 1 | Jul 15, 2026 | |
| GH Guardant Health | Reiterated: Buy | $61 → $129 | $161.41 | -20.08% | 11 | Feb 23, 2026 | |
| MYGN Myriad Genetics | Maintained: Buy | $8 | $3.19 | +150.78% | 9 | Jan 13, 2026 | |
| AZTA Azenta | Reiterated: Buy | $35 → $45 | $31.33 | +43.63% | 4 | Nov 25, 2025 | |
| AVTR Avantor | Downgraded: Hold | n/a | $14.97 | - | 15 | Nov 4, 2025 | |
| RVTY Revvity | Reiterated: Buy | $115 | $130.22 | -11.69% | 8 | Oct 28, 2025 | |
| QDEL QuidelOrtho | Maintained: Buy | $60 → $55 | $13.97 | n/a | 28 | Aug 6, 2025 | |
| FLGT Fulgent Genetics | Reiterated: Buy | $25 | $19.73 | n/a | 4 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $525 → $535 | $613.78 | n/a | 7 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $207.66 | n/a | 7 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $288.79 | n/a | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $17.38 | n/a | 16 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $175 | $328.18 | n/a | 9 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $50.88 | n/a | 25 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $4.70 | n/a | 1 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $42.53 | n/a | 9 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.48 | n/a | 14 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,050 | $0.0001 | n/a | 11 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $27.80 | n/a | 2 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $535.38 | n/a | 3 | Feb 2, 2021 |
Haemonetics
Sep 3, 2026
Maintained: Buy
Price Target: $105 → $125
Current: $102.92
Upside: +21.45%
Integer Holdings
Aug 3, 2026
Downgraded: Hold
Price Target: n/a
Current: $126.50
Upside: -
HCA Healthcare
Jul 15, 2026
Reiterated: Hold
Price Target: n/a
Current: $405.00
Upside: -
Guardant Health
Feb 23, 2026
Reiterated: Buy
Price Target: $61 → $129
Current: $161.41
Upside: -20.08%
Myriad Genetics
Jan 13, 2026
Maintained: Buy
Price Target: $8
Current: $3.19
Upside: +150.78%
Azenta
Nov 25, 2025
Reiterated: Buy
Price Target: $35 → $45
Current: $31.33
Upside: +43.63%
Avantor
Nov 4, 2025
Downgraded: Hold
Price Target: n/a
Current: $14.97
Upside: -
Revvity
Oct 28, 2025
Reiterated: Buy
Price Target: $115
Current: $130.22
Upside: -11.69%
QuidelOrtho
Aug 6, 2025
Maintained: Buy
Price Target: $60 → $55
Current: $13.97
Upside: n/a
Fulgent Genetics
Aug 4, 2025
Reiterated: Buy
Price Target: $25
Current: $19.73
Upside: n/a
Jul 24, 2025
Maintained: Buy
Price Target: $525 → $535
Current: $613.78
Upside: n/a
Jul 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $207.66
Upside: n/a
Mar 28, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $288.79
Upside: n/a
Feb 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $17.38
Upside: n/a
Feb 10, 2025
Reiterated: Buy
Price Target: $85 → $175
Current: $328.18
Upside: n/a
May 13, 2024
Downgraded: Hold
Price Target: n/a
Current: $50.88
Upside: n/a
Jul 18, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $4.70
Upside: n/a
Feb 22, 2023
Reiterated: Hold
Price Target: n/a
Current: $42.53
Upside: n/a
Feb 15, 2023
Maintained: Hold
Price Target: n/a
Current: $3.48
Upside: n/a
Feb 24, 2022
Maintained: Buy
Price Target: $1,050
Current: $0.0001
Upside: n/a
Feb 11, 2021
Reiterated: Hold
Price Target: n/a
Current: $27.80
Upside: n/a
Feb 2, 2021
Reiterated: Hold
Price Target: n/a
Current: $535.38
Upside: n/a